By: Angela Garrity
MedCity News is reporting that Dr. Brett Giroir is being considered as the next FDA commissioner.
Health and Human Services Secretary Alex Azar is mulling the idea of nominating Giroir, currently serving as Azar’s assistant secretary of HHS for health, as the head person of the FDA. Giroir has been serving since February 2018 and leads development of HHS-wide public health policy recommendations and oversees public health offices, such as the U.S. Public Health Service Commissioned Corps – in which he is a four-star admiral – and the Office of the Surgeon General.
Acting FDA commissioner, Ned Sharpless, could also be appointed to officially lead the agency, as well.
President Donald Trump has until November 1 to choose a new leader for the FDA, under the Federal Vacancies Reform Act of 1998, which states that a person can serve as an acting FDA commissioner for 210 days after the previously commissioner vacates the position. The position was previously held by Scott Gottlieb, who vacated the role in March.
Read the full article here.